Phase II and Pharmacological Study of Oral Docetaxel Plus Cyclosporin A in Anthracycline Pre-Treated Metastatic Breast Cancer.

Conclusion: Weekly oral docetaxel, combined with the booster drug CsA, is an active and safe treatment in anthracycline pre-treated patients with advanced breast cancer.
PMID: 24219005 [PubMed - as supplied by publisher]

Source: Clinical Breast Cancer - November 11, 2013 Category: Cancer & Oncology Authors: Helgason H, Koolen S, van Werkhoven E, Malingré M, Kruijtzer C, Huitema A, Schot M, Smit W, Beijnen J, Schellens J Tags: Curr Clin Pharmacol Source Type: research